UBS Group »

Merrimack Pharma shares owned by UBS Group

Quarter-by-quarter ownership of Merrimack Pharma (MACK) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Merrimack Pharma

Tip: Access up to 7 years of quarterly data

All positions including Merrimack Pharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merrimack Pharma by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $177k 13k 13.41
2023-09-30 $72k 5.8k 12.33
2023-06-30 $81k 6.6k 12.30
2023-03-31 $38k 3.1k 12.29
2022-12-31 $8.9k 775 11.46
2022-09-30 $0 5.2k 0.00
2022-06-30 $12k 1.2k 10.00
2022-03-31 $23k 2.3k 10.00
2021-12-31 $999 197 5.08
2021-09-30 $999 197 5.08
2021-06-30 $2.5k 499 5.08
2021-03-31 $10k 1.7k 6.02
2020-12-31 $999 197 5.08
2020-09-30 $999 197 5.08
2020-06-30 $999 197 5.08
2020-03-31 $5.4k 2.6k 2.12
2019-12-31 $1.0k 197 5.08
2019-09-30 $14k 2.8k 5.03
2019-06-30 $4.0k 597 6.70
2019-03-31 $13k 2.1k 6.04
2018-12-31 $16k 3.9k 4.02
2018-09-30 $13k 2.2k 6.04
2018-06-30 $11k 2.1k 5.10
2018-03-31 $4.0k 517 7.74
2017-12-31 $70k 6.8k 10.37
2017-09-30 $105k 7.3k 14.46